DuPont de Nemours Stock: Is Wall Street Bullish or Bearish?

Barchart
Ouvrir sur Barchart
DuPont de Nemours Stock: Is Wall Street Bullish or Bearish?

DuPont de Nemours, Inc. (DD) is a Wilmington, Delaware-based global multi-industrial company that develops and manufactures advanced materials, specialty products, and technology-based solutions for healthcare, water treatment, construction, and industrial applications. The company serves customers across multiple industries through its two operating segments: Healthcare & Water Technologies and Diversified Industrials. It is currently valued at a market cap of $19.1 billion.

Shares of this chemical giant have outperformed the broader market over the past year. DD has gained 26.3% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 12.2%. Over the past six months, the stock rose marginally, trailing the SPX’s 1.6% rise on a YTD basis. 

More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.

 

Zooming in further, DD has outpaced the State Street Materials Select Sector SPDR ETF (XLB), which has gained about 19.3% over the past year and has matched its marginal rise over the past six months. 

www.barchart.com

On Nov. 3, DuPont de Nemours shares rose 8.6% after the company reported strong third-quarter 2026 results, exceeding its financial guidance, supported by organic sales growth across both operating segments and improved operating margins. Net sales increased 4.1% year over year to $1.87 billion, while organic sales grew 5%. Operating EBITDA rose 7.6% to $469 million, with margins expanding 80 basis points to 25.1%. Adjusted EPS increased 62% to $2.09 from $1.29 in the prior-year quarter. The company also announced its intent to repurchase $250 million of shares in the fourth quarter

For the current fiscal year, ending in December, analysts expect DD’s EPS to grow 49% to $7.51 on a diluted basis. The company’s earnings surprise history is impressive. It beat the consensus estimate in each of the last four quarters.

Among the 17 analysts covering DD stock, the consensus is a “Moderate Buy.” That’s based on 11 “Strong Buy” ratings, one “Moderate Buy,” and five “Holds.”

www.barchart.com

This consensus is bearish than two months ago, when the stock had an overall “Strong Buy” rating.

On November 9, BMO Capital raised its price target on DuPont de Nemours to $190 from $186, maintaining an “Outperform” rating. The firm expressed confidence in DuPont's ability to sustain above-target performance, citing mid-single-digit growth despite challenging market conditions and an expected acceleration in growth through 2027. BMO attributed the company's strong performance to product innovation, exposure to attractive end markets, and margin expansion driven by efficiency improvements, solid pricing, and the initial implementation of its 80/20 strategy in the Diversified Industrials (D&I) segment.

The mean price target of $168.82 represents a 9.8% premium to DD’s current price levels. The Street-high price target of $186 suggests a notable upside potential of 21%.


On the date of publication, Kritika Sarmah did not directly have a position in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

 

More news from Barchart

Demand for the Anthropic IPO Far Outpaces Available Shares. Be Careful in an Early Scramble for Stock. Option Volatility and Earnings Report For Nov 16-20 U.S. Futures Slip as Chip Stocks Extend Slump; Nvidia Earnings and Anthropic IPO Awaited Could Last Friday's Events Have Ripple Effects for This Week's Markets?